OA08754A - Nouveaux dérivés de l'acide aza-2 bicyclooctane carboxylique-3, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent. - Google Patents

Nouveaux dérivés de l'acide aza-2 bicyclooctane carboxylique-3, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.

Info

Publication number
OA08754A
OA08754A OA59416A OA59416A OA08754A OA 08754 A OA08754 A OA 08754A OA 59416 A OA59416 A OA 59416A OA 59416 A OA59416 A OA 59416A OA 08754 A OA08754 A OA 08754A
Authority
OA
OAPI
Prior art keywords
formula
derivative
see diagramm
iii
compound
Prior art date
Application number
OA59416A
Other languages
English (en)
French (fr)
Inventor
Vincent Michel
Remond Georges
Laubie Michel
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of OA08754A publication Critical patent/OA08754A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
OA59416A 1987-08-28 1988-08-26 Nouveaux dérivés de l'acide aza-2 bicyclooctane carboxylique-3, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent. OA08754A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8712013A FR2619813B1 (fr) 1987-08-28 1987-08-28 Nouveaux derives de l'acide aza - 2 bicyclooctane carboxylique - 3, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
OA08754A true OA08754A (fr) 1989-03-31

Family

ID=9354475

Family Applications (1)

Application Number Title Priority Date Filing Date
OA59416A OA08754A (fr) 1987-08-28 1988-08-26 Nouveaux dérivés de l'acide aza-2 bicyclooctane carboxylique-3, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.

Country Status (16)

Country Link
US (1) US4959372A (de)
EP (1) EP0305297B1 (de)
JP (1) JPS6471875A (de)
AT (1) ATE52789T1 (de)
AU (1) AU612689B2 (de)
CA (1) CA1327800C (de)
DE (1) DE3860148D1 (de)
DK (1) DK170978B1 (de)
ES (1) ES2031616T3 (de)
FR (1) FR2619813B1 (de)
GR (1) GR3000677T3 (de)
IE (1) IE60505B1 (de)
NZ (1) NZ225943A (de)
OA (1) OA08754A (de)
PT (1) PT88357B (de)
ZA (1) ZA886368B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2655989B1 (fr) * 1989-12-20 1992-02-28 Adir Nouveaux derives d'amino-acides substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5458883A (en) * 1994-01-12 1995-10-17 Duke University Method of treating disorders of the eye
EP1233811A2 (de) * 1999-11-12 2002-08-28 Leo Rubin Verfahren zur behandlung von herzstillstand oder pulmonarer hypertension und substanzen zur verwendung dafür mit vasoaktivem intestinalen polypeptid und kardiales gerät zur elektrischen und chemischen regulation sowie verwendungsverfahren dafür
JPWO2002076981A1 (ja) * 2001-03-26 2004-10-07 壽製薬株式会社 イソキヌクリジン誘導体及びその製造方法並びにこれを含有する医薬組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL58849A (en) * 1978-12-11 1983-03-31 Merck & Co Inc Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them
FR2492381A1 (fr) * 1980-10-21 1982-04-23 Science Union & Cie Nouveaux acides aza bicyclo alcane carboxyliques substitues leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme
DE3227055A1 (de) * 1982-07-20 1984-01-26 Hoechst Ag, 6230 Frankfurt Neue derivate der 2-aza-bicyclo(2.2.2)octan-3-carbonsaeure, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung sowie 2-aza-bicyclo(2.2.2)octan-3-carbonsaeure als zwischenstufe und verfahren zu deren herstellung

Also Published As

Publication number Publication date
FR2619813A1 (fr) 1989-03-03
ATE52789T1 (de) 1990-06-15
ZA886368B (en) 1989-05-30
DK170978B1 (da) 1996-04-09
DK472788D0 (da) 1988-08-24
FR2619813B1 (fr) 1991-05-03
DE3860148D1 (de) 1990-06-21
GR3000677T3 (en) 1991-09-27
CA1327800C (fr) 1994-03-15
NZ225943A (en) 1990-06-26
AU612689B2 (en) 1991-07-18
DK472788A (da) 1989-03-01
AU2159488A (en) 1989-03-09
JPS6471875A (en) 1989-03-16
IE60505B1 (en) 1994-07-27
PT88357A (pt) 1989-06-30
EP0305297A1 (de) 1989-03-01
PT88357B (pt) 1995-03-31
IE882599L (en) 1989-02-28
ES2031616T3 (es) 1992-12-16
US4959372A (en) 1990-09-25
EP0305297B1 (de) 1990-05-16

Similar Documents

Publication Publication Date Title
US4035507A (en) Novel, transient pro-drug forms of L-DOPA to treat Parkinson's disease
AU582600B2 (en) Dipeptide compounds having pharmaceutical activity and compositions containing them
KR960004858B1 (ko) 프롤리날 유도체, 이의 제조방법 및 이를 함유하는 약제학적 조성물
US3998799A (en) Novel, transient pro-drug forms of l-dopa
RU96118225A (ru) Циклопептиды, способ их получения, содержащая их фармацевтическая композиция, способ ее получения, способ борьбы с заболеваниями, способ получения иммобилизированных лигандов, способ очистки интегринов
JPS6120544B2 (de)
HU188439B (en) Process for producing amino acid derivatives substituted by hexahydro-indole and pharmaceutics containing them as active substance
US4065566A (en) N-Nicotinoyl-3,4-dinicotinoyloxy-L-phenylalanine and derivatives pharmaceutical compositions and methods containing same
IL84570A0 (en) Diphosphonic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing them
PT91539B (pt) Processo para a preparacao de novos derivados peptidicos com accao antagonista do neuropeptido y
WO1988006448A1 (en) Prostaglandins useful for lowering intraocular pressure
OA08754A (fr) Nouveaux dérivés de l'acide aza-2 bicyclooctane carboxylique-3, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
OA09454A (fr) Nouveaux dérivés peptidiques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
FR2605004A1 (fr) Nouveaux derives d'amino-acides, leur procede de preparation et composition pharmaceutiques les contenant
EP0046292A1 (de) Substituierte Caprylolactam-Derivate als Antihypertonika, Verfahren zur Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzung
FR2392023A1 (fr) Nouveaux trans-5-aryl-2,3,4,4a,5,9,b-hexahydro-1h-pyrido (4,3-b) indoles, leur procede de preparation et composition pharmaceutique les contenant
EP0203450B1 (de) Neue Derivate bicyclischer Aminosäuren, Verfahren zu ihrer Herstellung, diese enthaltende Mittel und deren Verwendung
DE3462261D1 (en) Derivatives of isoindoledicarboxylic acids, their preparation and pharmaceutical compositions thereof
Chen et al. Synthesis of 2 (S)‐benzyl‐3‐[hydroxy (1′(R)‐amino ethyl) phosphinyl] propanoyl‐L‐3‐[125I]‐iodotyrosine: a radiolabelled inhibitor of aminopeptidase N
US4372973A (en) 16-Amino-postaglandin derivatives, their acid addition salts, and a process for the preparation thereof
FI84481B (fi) Foerfarande foer framstaellning av nya antihypertensiva 7-amino-1,2,3,4,6,7,8,12b-oktahydro-6-oxopyrido/2,1-a// 2/-bensazepin-4-karboxylsyraderivat.
KR910002787A (ko) 아크릴산 아미드유도체, 이들의 제조방법, 이들을 함유하는 약리학적 조성물 및 이들을 사용하는 약품
PT99964A (pt) Derivados de partricina processo para a sua preparacao e composicoes farmaceuticas que os contem